Bradykinin-induced reductions in collagen gene expression involve prostacyclin

Hypertension

Volumn 32, Issue 1, 1998, Pages 84-88

  Gallagher, Ann Marie ^a   Yu, Hisahiro ^a   Printz, Morton P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bradykinin; Collagen; Fibroblasts; Prostaglandins; Rabbits

Indexed keywords

ARACHIDONIC ACID; BERAPROST; BRADYKININ; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDOMETACIN; PROSTACYCLIN;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; HEART MUSCLE; HEART MUSCLE FIBROSIS; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RABBIT;

EID: 0031878685     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.1.84     Document Type: Article

References (35)

1. Ambrosioni E, Borghi C, Magnani B. The effects of angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med. 1995;332:80-85.
2. GISSI-3. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994;343:1115-1122.
3. Tan LB, Brilla C, Weber KT. Prevention of structural changes in the heart in hypertension by angiotensin converting enzyme inhibition. J Hypertens. 1992;10:S31-S34.
4. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation. 1991;83:1771-1779.
5. Linz W, Wiemer G, Schaper J, Zimmermann R, Nagasawa K, Gohlke P, Linger T, Scholkens BA. Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis. Mol Cell Biochem. 1995;147:89-97.
6. Jugdutt BI, Khan MI, Jugdutt SJ, Blinston GE. Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog. Circulation. 1995;91:802-812.
7. Liu Y-H, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: role of kinins and angiotensin II type 2 receptors. J Clin Invest. 1997;99: 1926-1935.
8. Michel J-B, Lattion AL, Salzmann JL, de Lourdes Cerol M, Philippe M, Camilleri J-P, Corvol P. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res. 1988;62: 641-650.
9. Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, Drexler H. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation. 1994;89:2273-2282.
10. 2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril Br J Pharmacol. 1992;105:771-772.
11. McDonald KM, Mock J, D'Aloia A, Parrish T, Hauer K, Francis G, Stillman A, Cohn JN. Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis. Circulation. 1995;91: 2043-2048.
12. 2+ entry in cardiac fibroblasts. Circulation. 1996;94:I-713. Abstract.
13. Zhou G, Tyagi SC, Weber KT. Bradykinin regulates collagen turnover in cardiac fibroblasts. Clin Res. 1993;41:630A. Abstract.
14. Burch RM. Bradykinin signal transduction in fibroblasts. Agents Actions Suppl. 1992;38:87-92.
15. Goldstein RH, Polgar P. The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts. J Biol Chem. 1982;257:8630-8633.
16. McAllister BS, Leeb-Lundberg LMF, Javors MA, Olson MS. Bradykinin receptors and signal transduction pathways in human fibroblasts: integral role for extracellular calcium. Arch Biochem Biophys. 1993;304: 294-301.
17. Sundqvist G, Rosenquist JB, Lerner UH. Effects of bradykinin and thrombin on prostaglandin formation, cell proliferation and collagen biosynthesis in human dental-pulp fibroblasts. Arch Oral Biol. 1995;40: 247-256.
18. Zhang H, Gaginella TS, Chen X, Cornwell DG. Action of bradykinin at the cyclooxygenase step in prostanoid synthesis through the arachidonic acid cascade. Agents Actions. 1991;34:397-404.
19. Weber DR, Stroud ED, Prescott SM. Arachidonate metabolism in cultured fibroblasts derived from normal and infarcted canine heart. Circ Res. 1989;65:671-683.
20. Yu H, Gallagher AM, Garfin PM, Printz MP. Prostacyclin release by rat cardiac fibroblasts: inhibition of collagen expression. Hypertension. 1997;30:1047-1053.
21. Coyne DW, Mordhorst M, Morrison AR. Regulation of eicosanoid biosynthesis by phorbol ester in Madin Darby canine kidney cells. Am J Physiol. 1990;259:F698-F703.
22. 2 production via a phospholipase D-linked mechanism. J Immunol. 1994;152:5032-5040.
23. Bruggeman LA, Pellicoro JA, Horigan EA, Klotman PE. Thromboxane and prostacyclin differentially regulate murine extracellular matrix gene expression. Kidney Int. 1993;43:1219-1225.
24. 2. J Biol Chem. 1993;268:10364-10371.
25. 2 causes a coordinate decrease in the steady state levels of fibronectin and types I and III procollagen mRNAs in normal human dermal fibroblasts. Biochem Biophys Res Commun. 1987;147:1282-1288.
26. Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation. 1993;88:2849-2861.
27. Gerritsen ME, Printz MP. Sites of prostaglandin synthesis in the bovine heart and isolated bovine coronary microvessels. Circ Res. 1981;49: 1152-1163.
28. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A. 1984;81:1991-1995.
29. Barbu V, Dautry F. Northern blot normalization with a 28S rRNA oligonucleotide probe. Nucleic Acids Res. 1989;17:7115.
30. Carver W, Nagpal ML, Nachtigal M, Borg TK, Terracio L. Collagen expression in mechanically stimulated cardiac fibroblasts. Circ Res. 1991; 69:116-122.
31. Bishop JE, Greenbaum R, Gibson DG, Yacoub M, Laurent GL. Enhanced deposition of predominantly type I collagen in myocardial disease. J Mol Cell Cardiol. 1990;22:1157-1165.
32. Medugorac I, Jacob R. Characterization of left ventricular collagen in the rat. Cardiovasc Res. 1983;17:15-21.
33. Mukherjee D, Sen S. Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats. Circ Res. 1990;67:1474-1480.
34. 1-adrenoreceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog. Circulation. 1994;90:3034-3046.
35. Wollert KC, Studer R, Doerfer K, Schieffer E, Holubarsch C, Just H, Drexler H. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat. Circulation. 1997;95:1910-1917.